Ads
related to: antibody
Search results
New COVID-19 'FLiRT' Variants Are The Most Dominant In The U.S.
Women's Health via AOL· 11 hours agoThose who are more vulnerable to getting sick during a spring or summer surge may benefit from the...
In a 1st, HIV vaccine triggers rare and elusive antibodies in human patients
Live Science via Yahoo News· 14 hours agoIllustration of an HIV virus particule being swarmed by y-shaped antibodies. An HIV vaccine is one...
Duke University's HIV Vaccine Shows Promise in Triggering Crucial Antibodies
Gadgets 360· 17 hours agoA recent breakthrough in HIV vaccine research at Duke University Medical Center has stirred hope in...
Genmab completes $1.8 billion acquisition of ProfoundBio By Investing.com
Investing.com· 13 hours agoGenmab A/S (NASDAQ:GMAB), a biotechnology company specializing in antibody therapeutics, has...
Innovent Announces the New Drug Application of IBI311 (IGF-1R antibody) has been Accepted by the...
WTNH-TV New Haven· 1 day ago...medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and other major...
AstraZeneca to establish $1.5bn ADC production site in Singapore
Pharmaceutical Technology via Yahoo Finance· 21 hours agoAstraZeneca is set to invest $1.5bn in a new manufacturing facility in Singapore dedicated to...
Experimental HIV Vaccine Successfully Triggers Potent Antibodies in Humans
ScienceAlert via Yahoo News· 22 hours agoFor a vaccine to work, it has to raise antibodies in the immunized – antibodies that are primed to neutralize subsequent intruders. For a vaccine to be safe, it has to do so for the vast majority ...
Temple Street Biotech Initiates Groundbreaking Therapeutic Antibody for Alzheimer's Disease
FOX 5 San Diego· 10 hours agoTemple Street Biotech is proud to announce the initiation of a pioneering therapeutic antibody targeting prion protein for the treatment of Alzheimer's disease. This project ...
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WKBN 27 Youngstown· 9 hours agoAvidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs ...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 11 hours agoBroadly, AstraZeneca aims to develop drugs that supplant toxic chemotherapies as well as...
